课题基金 / 基金详情

Role of beta-amyloid peptides in regulating the function/survival of central cholinergic neurons and its implications in Alzheimer's disease pathology

Role of beta-amyloid peptides in regulating the function/survival of central cholinergic neurons and its implications in Alzheimer's disease pathology
β-淀粉样肽在调节中枢胆碱能神经元功能/存活中的作用及其在阿尔茨海默病病理学中的意义
批准号:
179530
负责人:
Kar Satyabrata
金额:
$37.22万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-03-01 至 2014-03-01

项目摘要

项目成果

Kar Satyabrata的其他基金

相似基金

相关文献

中文摘要
翻译
阿尔茨海默病(Alzheimer's disease,AD)是一种进行性神经退行性疾病,其特征是记忆逐渐丧失,随后出现高级认知功能如语言、计算和判断的退化。与脑梗死相关的神经病理学特征
英文摘要
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by a gradual loss of memory followed by deterioration of higher cognitive functions such as language, calculation and judgment. The neuropathological features associated wi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Native PLGA nanoparticles attenuate aggregation, phosphorylation and internalization of tau protein: potential implication in the treatment of Alzheimer's disease
  • 批准号:
    487617
  • 项目类别:
    Operating Grants
  • 资助金额:
    $72.17万
  • 财政年份:
    2023
  • 负责人:
    Kar Satyabrata
  • 依托单位:
Biodegradable acidic nanoparticles attenuate beta-amyloid aggregation/toxicity: potential implication in the treatment of Alzheimer's disease pathology
  • 批准号:
    443438
  • 项目类别:
    Operating Grants
  • 资助金额:
    $53.22万
  • 财政年份:
    2021
  • 负责人:
    Kar Satyabrata
  • 依托单位:
Role of lysosomal enzymes cathepsins B and D in neuronal vulnerability: potential implications in Alzheimer's disease pathology
  • 批准号:
    369603
  • 项目类别:
    Operating Grants
  • 资助金额:
    $54.06万
  • 财政年份:
    2017
  • 负责人:
    Kar Satyabrata
  • 依托单位:
Role of activated astrocytes in APP metabolism and its functional implications in Alzheimer's disease pathology
  • 批准号:
    357782
  • 项目类别:
    Operating Grants
  • 资助金额:
    $49.6万
  • 财政年份:
    2016
  • 负责人:
    Kar Satyabrata
  • 依托单位:
海外基金